Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2006

01-11-2006 | Case Report

Hyperbaric Oxygen in Addition to Antibiotic Therapy Is Effective for Bisphosphonate-Induced Osteonecrosis of the Jaw in a Patient with Multiple Myeloma

Authors: Kazuho Shimura, Chihiro Shimazaki, Kyoko Taniguchi, Sonoko Akamatsu, Masashi Okamoto, Ryo Uchida, Ken-ichi Nomura, Tohru Inaba, Shigeo Horiike, Narisato Kanamura, Masafumi Taniwaki

Published in: International Journal of Hematology | Issue 4/2006

Login to get access
Metadata
Title
Hyperbaric Oxygen in Addition to Antibiotic Therapy Is Effective for Bisphosphonate-Induced Osteonecrosis of the Jaw in a Patient with Multiple Myeloma
Authors
Kazuho Shimura
Chihiro Shimazaki
Kyoko Taniguchi
Sonoko Akamatsu
Masashi Okamoto
Ryo Uchida
Ken-ichi Nomura
Tohru Inaba
Shigeo Horiike
Narisato Kanamura
Masafumi Taniwaki
Publication date
01-11-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06110

Other articles of this Issue 4/2006

International Journal of Hematology 4/2006 Go to the issue

OriginalPaper

TEL/ETV6 Binds to Corepressor KAP1 via the HLH Domain

OriginalPaper

Overview: Helicobacter pylori and Extragastric Disease

OriginalPaper

Expression of CD27 on Peripheral CD4+ T-Lymphocytes Correlates with the Development of Severe Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation

OriginalPaper

The Role of Helicobacter pylori CagA in Gastric Carcinogenesis

OriginalPaper

Helicobacter pylori and Immune Thrombocytopenic Purpura: Unsolved Questions and Controversies

OriginalPaper

Posttransplantation Engraftment and Safety of Cord Blood Transplantation with Grafts Containing Relatively Low Cell Doses in Adults
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits